Research location
Sepulveda
California, United States
Advertisement
Research activity in Sepulveda
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 31 trials and 31 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sepulveda
31 linked trials · page 1 of 1Cardiovascular Risk Screening and Risk Reduction in Women VetsNCT02991534 · 2016-11-15 · 1 site observation
COMPLETED
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow LimitationNCT01712516 · 2012-12-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2NCT01052714 · 2010-09-01 · 1 site observation
COMPLETED
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyNCT01110200 · 2010-04-30 · 1 site observation
COMPLETED
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01053988 · 2009-10-05 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01009463 · 2009-09-25 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseNCT00877383 · 2009-04-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.NCT00528996 · 2007-09-06 · 1 site observation
COMPLETED
Cobiprostone Prevention of NSAID-induced Gastroduodenal InjuryNCT00597818 · 2007-08-01 · 1 site observation
COMPLETED
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate TherapyNCT00405275 · 2007-07-01 · 1 site observation
COMPLETED
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00463567 · 2007-04-01 · 1 site observation
COMPLETED
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDNCT00419744 · 2007-01-01 · 1 site observation
COMPLETED
Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)NCT00400153 · 2006-11-01 · 1 site observation
COMPLETED
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.NCT00388882 · 2006-10-04 · 1 site observation
COMPLETED
Coronary Artery Revascularization in DiabetesNCT00326196 · 2006-07-01 · 1 site observation
TERMINATED
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDNCT00308191 · 2006-04-01 · 1 site observation
COMPLETED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation
COMPLETED
Dose Finding Study in COPDNCT00122434 · 2005-07-01 · 1 site observation
COMPLETED
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsNCT00206154 · 2005-04-01 · 1 site observation
COMPLETED
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)NCT00103922 · 2004-11-01 · 1 site observation
COMPLETED
ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.NCT00144911 · 2004-10-01 · 1 site observation
COMPLETED
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary DiseaseNCT00106821 · 2004-06-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II PatientsNCT00240448 · 2003-09-01 · 1 site observation
COMPLETED
Evaluation Study of TIDES Depression Care Quality Improvement InterventionNCT00105820 · 2003-06-01 · 1 site observation
COMPLETED
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD PatientsNCT00144339 · 2002-12-01 · 1 site observation
COMPLETED
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.NCT00274560 · 2002-05-01 · 1 site observation
COMPLETED
Warfarin and Antiplatelet Therapy in Chronic Heart FailureNCT00007683 · 1998-10-01 · 1 site observation
COMPLETED
Prostate Cancer Intervention Versus Observation Trial (PIVOT)NCT00007644 · 1994-11-01 · 1 site observation
COMPLETED
Hypertension Screening and Treatment ProgramNCT00007592 · 1989-06-01 · 1 site observation
COMPLETED
Study in Patients With COPDNCT00215449 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.